---
title: Pharma Inventor vs ResolveMass Laboratories Inc.
slug_a: pharmainventor
slug_b: resolvemass
site: cro
review_signal_gate: closed
canonical_path: /compare/pharmainventor/resolvemass
---

# Pharma Inventor vs ResolveMass Laboratories Inc.

Side-by-side profile data from each company listing on this directory.

## Pharma Inventor

- Profile: [/companies/pharmainventor](/companies/pharmainventor)

Pharma Inventor — Pharma Inventor is a Vancouver-based preclinical drug discovery CRO offering medicinal chemistry, custom synthesis, analytical, bioanalytical, and biology services to pharmaceutical and biotech teams.

Services: 11. Modalities: 4. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Analytical Method Development & Validation

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Peptide
- Radiopharmaceutical

### Indications

- Data not yet provided.

### Phases

- Discovery

### Sourcing models

- Functional Service Provider (FSP)

## ResolveMass Laboratories Inc.

- Profile: [/companies/resolvemass](/companies/resolvemass)

ResolveMass Laboratories Inc. — Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (4).

### Services

- Medicinal Chemistry
- Regulatory Affairs
- US FDA Regulatory Strategy
- Analytical Method Development & Validation

### Modalities

- Small Molecule
- Peptide

### Indications

- Data not yet provided.

### Phases

- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)